BridgeBio Pharma lists 10 executives, led by Neil Kumar Ph.D., Co-Founder, CEO & Director (age 46). Thomas Trimarchi Ph.D. is the company's CFO & President (age 40).
In fiscal year 2025 the highest-paid executive was Neil Kumar Ph.D., Co-Founder, CEO & Director, with total pay of $2.46 million. The 6 executives with reported pay received $6.64 million in all.
The average age of the executives with a known age is 59; the youngest is 40 and the oldest 77.
Titles, ages and pay from company filings; pay for fiscal year 2025.

Co-Founder, CEO & Director
CFO & President
Co-Founder, Chairman of Pharmaceuticals & Lead Director
Co-Founder, Chairman of Oncology & Director
Chief Accounting Officer
Chief Scientific Officer
Chairman of Research & Development
Chief Scientific Officer of Oncology
Chief Executive Officer of Gene Therapy
Chief Commercial Officer
| Executive | Title | Age | Total pay |
|---|---|---|---|
| Neil Kumar Ph.D. | Co-Founder, CEO & Director | 46 | $2.46 million |
| Uma Sinha Ph.D. | Chief Scientific Officer | 67 | $1.31 million |
| Thomas Trimarchi Ph.D. | CFO & President | 40 | $1.23 million |
| Charles J. Homcy M.D. | Co-Founder, Chairman of Pharmaceuticals & Lead Director | 77 | $574,167 |
| Frank P. McCormick Ph.D. | Co-Founder, Chairman of Oncology & Director | 75 | $550,000 |
| Richard H. Scheller Ph.D. | Chairman of Research & Development | 72 | $509,622 |
Total pay as reported for the fiscal year; it can include salary, bonus and stock awards.
Neil Kumar Ph.D. (Co-Founder, CEO & Director), age 46; total pay in fiscal year 2025 was $2.46 million.
Thomas Trimarchi Ph.D. (CFO & President), age 40.
Neil Kumar Ph.D., Co-Founder, CEO & Director, with total pay of $2.46 million in fiscal year 2025.
Neil Kumar Ph.D. (Co-Founder, CEO & Director), Thomas Trimarchi Ph.D. (CFO & President), Charles J. Homcy M.D. (Co-Founder, Chairman of Pharmaceuticals & Lead Director), Frank P. McCormick Ph.D. (Co-Founder, Chairman of Oncology & Director) and Maricel M. Apuli (Chief Accounting Officer), and 5 more.